The discovery of AZD0530: a novel, oral, highly selective and dual-specific inhibitor of the Src and Abl family kinases Laurent F. Hennequin,et al. Proc Amer Assoc Cancer Res. 2005;Volume 46
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 Tim P. Green,Mike Fennell,et al. MOLECULAR ONCOLOGY 2009;3:248–261
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.